Underdog Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Underdog Pharmaceuticals's estimated annual revenue is currently $1.2M per year.
- Underdog Pharmaceuticals's estimated revenue per employee is $77,500
- Underdog Pharmaceuticals's total funding is $17.5M.
Employee Data
- Underdog Pharmaceuticals has 15 Employees.
- Underdog Pharmaceuticals grew their employee count by 25% last year.
Underdog Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-CEO and Co-founder | Reveal Email/Phone |
2 | Executive Assistant To CEOs | Reveal Email/Phone |
3 | Computational Biochemist | Reveal Email/Phone |
4 | Principal Scientist | Reveal Email/Phone |
Underdog Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Underdog Pharmaceuticals?
Underdog Pharmaceuticals, Inc., is pursuing a mission to treat the underlying causes of age-related disease. The company develops simple and direct interventions targeting toxic forms of cholesterol, using rationally designed molecules, to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration.
keywords:N/A$17.5M
Total Funding
15
Number of Employees
$1.2M
Revenue (est)
25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Underdog Pharmaceuticals News
Orasis Pharmaceuticals probably doesn't think it's the underdog with the two Phase III results it has in hand for an eye drop meant to help...
Orasis Pharmaceuticals probably doesn't think it's the underdog with the two Phase III results it has in hand for an eye drop meant to help...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.8M | 15 | 15% | N/A |
#2 | $1.3M | 15 | 7% | N/A |
#3 | $1.3M | 15 | 7% | N/A |
#4 | $2.3M | 15 | 15% | N/A |
#5 | $1.3M | 15 | 25% | N/A |